ACON
Aclarion Inc
$
6.063
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
6.1326
Open
6.130
VWAP
6.10
Vol
2.88K
Mkt Cap
4.07M
Low
5.9825
Amount
17.58K
EV/EBITDA(TTM)
--
Total Shares
8.20M
EV
-7.31M
EV/OCF(TTM)
--
P/S(TTM)
31.36
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
50.00K
+158.8%
-3.840
-99.76%
50.00K
+163.3%
-2.640
-99.81%
Estimates Revision
The market is revising No Change the revenue expectations for Aclarion, Inc. (ACON) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -16.95%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-16.95%
In Past 3 Month
1 Analyst Rating
Wall Street analysts forecast ACON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACON is 22.00 USD with a low forecast of 22.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.063
Low
22.00
Averages
22.00
High
22.00
Current: 6.063
Low
22.00
Averages
22.00
High
22.00
Maxim Group
Anthony Vendetti
Strong Buy
to
Hold
Downgrades
n/a
2024-12-13
Reason
Maxim Group
Anthony Vendetti
Price Target
n/a
2024-12-13
Downgrades
Strong Buy
to
Hold
Reason
Maxim downgraded Aclarion to Hold from Buy.
Ascendiant Capital
Lucas Ward
Strong Buy
Maintains
$1.5 → $1.3
2024-11-27
Reason
Ascendiant Capital
Lucas Ward
Price Target
$1.5 → $1.3
2024-11-27
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Aclarion Inc (ACON.O) is -0.47, compared to its 5-year average forward P/E of -1.22. For a more detailed relative valuation and DCF analysis to assess Aclarion Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.22
Current PE
-0.47
Overvalued PE
-0.25
Undervalued PE
-2.20
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
27.45
Current PS
0.00
Overvalued PS
63.86
Undervalued PS
-8.95
Financials
Annual
Quarterly
FY2025Q3
YoY :
+31.48%
18.94K
Total Revenue
FY2025Q3
YoY :
+41.28%
-1.83M
Operating Profit
FY2025Q3
YoY :
+24.90%
-1.71M
Net Income after Tax
FY2025Q3
YoY :
-99.78%
-2.93
EPS - Diluted
FY2025Q3
YoY :
+3.55%
-1.20M
Free Cash Flow
FY2025Q3
YoY :
-148.16%
23.15
Gross Profit Margin - %
FY2025Q3
YoY :
-9.23%
-9.90K
FCF Margin - %
FY2025Q3
YoY :
-5.01%
-9.01K
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ACON News & Events
Events Timeline
2025-10-01 (ET)
2025-10-01
07:22:45
Aclarion Showcases Nociscan Technology at LSI Europe '25
2025-09-25 (ET)
2025-09-25
06:06:13
Aclarion Reports Initial Enrollment in Key CLARITY Trial
2025-09-03 (ET)
2025-09-03
06:01:20
Aclarion Appoints Greg Gould as CFO, Effective Immediately
Sign Up For More Events
Sign Up For More Events
News
4.0
11-20BenzingaNvidia Set to Surge by 72%? Check Out 10 Leading Analyst Predictions for Thursday
4.0
11-20BenzingaAscendiant Capital Reiterates Buy Rating on Aclarion, Increases Price Target to $23
5.0
11-05NewsfilterAclarion Names Dan Isherwood as UK Commercial Director to Enhance Adoption and Expand Market Reach
Sign Up For More News
People Also Watch
UK
Ucommune International Ltd
0.850
USD
-11.46%
BJDX
Bluejay Diagnostics Inc
1.270
USD
+0.79%
SBET
SharpLink Gaming Inc
9.520
USD
+2.37%
EZGO
EZGO Technologies Ltd
2.120
USD
+11.58%
JFBR
Jeffs Brands Ltd
1.450
USD
-3.97%
AKAN
Akanda Corp
0.895
USD
-2.50%
SXTC
China SXT Pharmaceuticals Inc
1.370
USD
+1.86%
WLDS
Wearable Devices Ltd
1.880
USD
-0.53%
FAQ
What is Aclarion Inc (ACON) stock price today?
The current price of ACON is 6.0628 USD — it has decreased -0.93 % in the last trading day.
What is Aclarion Inc (ACON)'s business?
What is the price predicton of ACON Stock?
What is Aclarion Inc (ACON)'s revenue for the last quarter?
What is Aclarion Inc (ACON)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Aclarion Inc (ACON)'s fundamentals?
How many employees does Aclarion Inc (ACON). have?